Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore comprehensive treatment updates for diffuse large B-cell lymphoma (DLBCL) in this one-hour educational webinar from Dana-Farber Cancer Institute's Lymph Notes learning series. Learn about current treatment considerations for newly-diagnosed DLBCL patients through insights from Dr. Jennifer Crombie, who covers initial therapeutic approaches and decision-making factors. Discover advanced treatment strategies for relapsed and refractory DLBCL cases as Dr. David Qualls discusses the latest options for patients whose disease has returned or proven resistant to initial therapy. Gain valuable knowledge about this aggressive form of non-Hodgkin lymphoma, including evolving treatment paradigms, patient selection criteria, and clinical considerations that inform therapeutic choices across different stages of the disease journey.
